Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Henk Joos Appointed Managing Director of FlandersBio

Published: Wednesday, January 15, 2014
Last Updated: Wednesday, January 15, 2014
Bookmark and Share
Henk’s objective is to maximize the valorization of the potential worldwide with FlandersBio.

The Board of Directors of FlandersBio has announced the appointment of Henk Joos as the new Managing Director of organization.

FlandersBio is the industrial networking organization for the life sciences sector in Flanders, a dynamic non-profit, fee-based organization with currently more than 280 members.

Henk (°1958, Roeselare) studied biology at the University of Ghent, where he obtained his PhD in 1984, after which he took the INSEAD Young Management Programme. Henk was active at Plant Genetic Systems (PGS) for a decade; first as a researcher and then as a business development manager.

After that he occupied various international management positions at, among others, AgrEvo, Aventis Cropscience, Bayer Cropscience, D1 oils and QUINVITA. Between 2004 and 2006 Henk was also a member of the FlandersBio’s Board of Directors. Therefore he was closely involved in the establishment of the organization.

“We are very pleased that Henk is joining the FlandersBio team as its Managing Director”, says Patrik De Haes, chairman of the Board of FlandersBio. “With his many years’ experience in the biotech sector, Henk can further develop FlandersBio into an integrated network that unites all actors. Several Flemish companies were at the outset of the industrialization of the various areas of biotechnology in Europe. The current Flemish biotech sector can therefore rely on a broad experience and an exceptional potential in this fast evolving and challenging business. Henk’s objective is to maximize the valorization of this potential worldwide with FlandersBio”.

Henk Joos is looking forward to his new position: “I consider becoming the Managing Director of FlandersBio a great honour, also at this historic moment in the existence of the organization, which is celebrating its 10th anniversary in 2014! FlandersBio has developed into a fascinating and extremely varied platform. I consider it my personal task to set up a very directional supportive policy for the members of FlandersBio. With the cluster of the FlandersBio member companies, Flanders has a unique flagship to further develop its knowledge economy internationally”.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Best Test to Diagnose Strangles in Horses Identified
New research by Dr. Ashley Boyle of New Bolton Center’s Equine Field Service team shows that the best method for diagnosing Strangles in horses is to take samples from a horse’s guttural pouch and analyze them using a loop-mediated amplification (LAMP) polymerase chain reaction (PCR) test.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
Detecting When Hormone Treatment for Breast Cancer Stops Working
Scientists have developed a highly sensitive blood test that can spot when breast cancers become resistant to standard hormone treatment, and have demonstrated that this test could guide further treatment.
Packaging and Unpacking of the Genome
New research improves understanding of the importance of histone replacement.
New Way to Find DNA Damage
University of Utah chemists devised a new way to detect chemical damage to DNA that sometimes leads to genetic mutations responsible for many diseases, including various cancers and neurological disorders.
How Different Treatments for Crohn's Effect the Microbiome
Different treatments for Crohn's disease in children affects their gut microbes in distinct ways, which has implications for future development of microbial-targeted therapies for these patients, according to a study led by researchers from the Perelman School of Medicine at the University of Pennsylvania.
Charting the 'Genomic Biography' of Leukemia
A new study by scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard offers a glimpse of the wealth of information that can be gleaned by combing the genome of a large collection of leukemia tissue samples.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos